2.75 semaglutide Wegovy 2.4 mg/0.75 mL pre-filled pen-injector Images A simple mistake led to

Survodutide (BI 456906), developed by Boehringer Ingelheim and Zealand Pharma, has completed Phase 2 trials for both obesity (up to 18.7% weight loss at 46 weeks) and MASH (62% MASH resolution), earning FDA Breakthrough Therapy Designation for MASH

5-Amino-1MQ at a glance What it is 5-Amino-1MQ (5-amino-1-methylquinolinium) a small-molecule quinolinium compound

Muscle is not just about how you look

Thiaminase II in fern extracts exerts an effect on neurotransmission which, similar to that of the thiamine antagonist pyrithiamine, can be counteracted by the addition of thiamine (177)

Stop eating when you feel full and eat only when you feel hungry

It is meant to set realistic expectations